{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:59:28Z","timestamp":1790629168051,"version":"4.1.0"},"reference-count":36,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2022.13628","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T11:34:53Z","timestamp":1670585693000},"source":"Crossref","is-referenced-by-count":13,"title":["Interference with pathways activated by topoisomerase inhibition alters the surface expression of PD\u2011L1 and MHC I in colon cancer cells"],"prefix":"10.3892","volume":"25","author":[{"given":"Mohamed","family":"Hassan","sequence":"first","affiliation":[{"name":"Tuskegee University College of Veterinary Medicine and Center for Biomedical Research, Tuskegee, AL 36088, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vu","family":"Trung","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, UAB Comprehensive Cancer Center, Birmingham Veterans Affairs Medical Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Bedi","sequence":"additional","affiliation":[{"name":"Tuskegee University College of Veterinary Medicine and Center for Biomedical Research, Tuskegee, AL 36088, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sage","family":"Shaddox","sequence":"additional","affiliation":[{"name":"Tuskegee University College of Veterinary Medicine and Center for Biomedical Research, Tuskegee, AL 36088, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip","family":"Gunturu","sequence":"additional","affiliation":[{"name":"Tuskegee University College of Veterinary Medicine and Center for Biomedical Research, Tuskegee, AL 36088, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton","family":"Yates","sequence":"additional","affiliation":[{"name":"Tuskegee University College of Veterinary Medicine and Center for Biomedical Research, Tuskegee, AL 36088, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pran","family":"Datta","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, UAB Comprehensive Cancer Center, Birmingham Veterans Affairs Medical Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temesgen","family":"Samuel","sequence":"additional","affiliation":[{"name":"Tuskegee University College of Veterinary Medicine and Center for Biomedical Research, Tuskegee, AL 36088, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"key":"key20230111131732_b1-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"key20230111131732_b2-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11888-017-0384-3","article-title":"Immunotherapy in colorectal cancer: Where are we now?","volume":"13","author":"Baybutt","year":"2017","journal-title":"Curr Colorectal Cancer Rep"},{"key":"key20230111131732_b3-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1200\/EDBK_200821","article-title":"Where we stand with immunotherapy in colorectal cancer: Deficient mismatch repair, proficient mismatch repair, and toxicity management","volume":"38","author":"Overman","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"key20230111131732_b4-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"key":"key20230111131732_b5-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11888-015-0269-2","article-title":"Immunotherapy of metastatic colorectal cancer: Prevailing challenges and new perspectives","volume":"11","author":"Zumwalt","year":"2015","journal-title":"Curr Colorectal Cancer Rep"},{"key":"key20230111131732_b6-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1158\/2326-6066.CIR-17-0375","article-title":"A blueprint to advance colorectal cancer immunotherapies","volume":"5","author":"Le","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"key20230111131732_b7-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1158\/1078-0432.CCR-15-2879","article-title":"Immune and stromal classification of colorectal cancer is associated with molecular subtypes and relevant for precision immunotherapy","volume":"22","author":"Becht","year":"2016","journal-title":"Clin Cancer Res"},{"key":"key20230111131732_b8-ol-25-01-13628","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1002\/ijc.24989","article-title":"High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients","volume":"126","author":"Frey","year":"2010","journal-title":"Int J Cancer"},{"key":"key20230111131732_b9-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1200\/JCO.2008.18.7229","article-title":"Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer","volume":"27","author":"Salama","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20230111131732_b10-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1158\/1078-0432.CCR-11-3216","article-title":"The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: A critical review of the literature","volume":"18","author":"deLeeuw","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20230111131732_b11-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"728842","DOI":"10.3389\/fonc.2021.728842","article-title":"The prognostic value of a tumor microenvironment-based immune cell infiltration score model in colon cancer","volume":"11","author":"Tang","year":"2021","journal-title":"Front Oncol"},{"key":"key20230111131732_b12-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3389\/fimmu.2019.01816","article-title":"Is there a place for immunotherapy for metastatic microsatellite stable colorectal cancer?","volume":"10","author":"Ghiringhelli","year":"2019","journal-title":"Front Immunol"},{"key":"key20230111131732_b13-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41420-021-00533-w","article-title":"NF-\u03baB is involved in the regulation of autophagy in mutant p53 cells in response to ionizing radiation","volume":"7","author":"Zhu","year":"2021","journal-title":"Cell Death Discov"},{"key":"key20230111131732_b14-ol-25-01-13628","first-page":"125","article-title":"Radiation-triggered NF-\u03baB activation is responsible for the angiogenic signaling pathway and neovascularization for breast cancer cell proliferation and growth","volume":"6","author":"Yu","year":"2012","journal-title":"Breast Cancer (Auckl)"},{"key":"key20230111131732_b15-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"9501","DOI":"10.1074\/jbc.275.13.9501","article-title":"NF-kappaB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events","volume":"275","author":"Huang","year":"2000","journal-title":"J Biol Chem"},{"key":"key20230111131732_b16-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"e5301","DOI":"10.1371\/journal.pone.0005301","article-title":"Cell survival from chemotherapy depends on NF-kappaB transcriptional up-regulation of coenzyme Q biosynthesis","volume":"4","author":"Brea-Calvo","year":"2009","journal-title":"PLoS One"},{"key":"key20230111131732_b17-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.1140321","article-title":"ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage","volume":"316","author":"Matsuoka","year":"2007","journal-title":"Science"},{"key":"key20230111131732_b18-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.tibs.2010.09.005","article-title":"ATR: A master conductor of cellular responses to DNA replication stress","volume":"36","author":"Flynn","year":"2011","journal-title":"Trends Biochem Sci"},{"key":"key20230111131732_b19-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.immuni.2018.03.007","article-title":"Combination cancer therapy with immune checkpoint blockade: Mechanisms and strategies","volume":"48","author":"Patel","year":"2018","journal-title":"Immunity"},{"key":"key20230111131732_b20-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Twyman-Saint Victor","year":"2015","journal-title":"Nature"},{"key":"key20230111131732_b21-ol-25-01-13628","first-page":"229","article-title":"Landscape of immunotherapy options for colorectal cancer: Current knowledge and future perspectives beyond immune checkpoint blockade","volume":"12","author":"Gorzo","year":"2022","journal-title":"Life (Basel)"},{"key":"key20230111131732_b22-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"784336","DOI":"10.3389\/fimmu.2021.784336","article-title":"Good tumor response to chemoradioimmunotherapy in dMMR\/MSI-H advanced colorectal cancer: A case series","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Immunol"},{"key":"key20230111131732_b23-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"e0157164","DOI":"10.1371\/journal.pone.0157164","article-title":"Optimizing timing of immunotherapy improves control of tumors by hypofractionated radiation therapy","volume":"11","author":"Young","year":"2016","journal-title":"PLoS One"},{"key":"key20230111131732_b24-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2017.01.012","article-title":"Chemoimmunotherapy by combining oxaliplatin with immune checkpoint blockades reduced tumor burden in colorectal cancer animal model","volume":"487","author":"Wang","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"key20230111131732_b25-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.clcc.2020.02.002","article-title":"Clinical development of immunotherapy for deficient mismatch repair colorectal cancer","volume":"19","author":"Thomas","year":"2020","journal-title":"Clin Colorectal Cancer"},{"key":"key20230111131732_b26-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"S3541","DOI":"10.1200\/JCO.2017.35.15_suppl.3541","article-title":"A phase II study of pembrolizumab in combination with mFOLFOX6 for patients with advanced colorectal cancer","volume":"35","author":"Shahda","year":"2017","journal-title":"J Clin Oncol"},{"key":"key20230111131732_b27-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41416-019-0599-y","article-title":"Immune checkpoint inhibitors for the treatment of MSI-H\/MMR-D colorectal cancer and a perspective on resistance mechanisms","volume":"121","author":"Sahin","year":"2019","journal-title":"Br J Cancer"},{"key":"key20230111131732_b28-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1158\/0008-5472.CAN-08-2023","article-title":"Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition","volume":"69","author":"Dallas","year":"2009","journal-title":"Cancer Res"},{"key":"key20230111131732_b29-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1186\/1471-2407-14-599","article-title":"Variable NF-\u03baB pathway responses in colon cancer cells treated with chemotherapeutic drugs","volume":"14","author":"Samuel","year":"2014","journal-title":"BMC Cancer"},{"key":"key20230111131732_b30-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/medicines6020051","article-title":"Camptothecin induces PD-L1 and immunomodulatory cytokines in colon cancer cells","volume":"6","author":"Bedi","year":"2019","journal-title":"Medicines (Basel)"},{"key":"key20230111131732_b31-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.molimm.2007.08.013","article-title":"Chemopreventive agents induce programmed death-1-ligand 1 (PD-L1) surface expression in breast cancer cells and promote PD-L1-mediated T cell apoptosi","volume":"45","author":"Zhang","year":"2008","journal-title":"Mol Immunol"},{"key":"key20230111131732_b32-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40425-016-0163-8","article-title":"5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers","volume":"4","author":"Van Der Kraak","year":"2016","journal-title":"J Immunother Cancer"},{"key":"key20230111131732_b33-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"31411","DOI":"10.18632\/oncotarget.25830","article-title":"Topoisomerase I inhibitor, irinotecan, depletes regulatory T cells and up-regulates MHC class I and PD-L1 expression, resulting in a supra-additive antitumor effect when combined with anti-PD-L1 antibodies","volume":"9","author":"Iwai","year":"2018","journal-title":"Oncotarget"},{"key":"key20230111131732_b34-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/s41467-017-01883-9","article-title":"DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells","volume":"8","author":"Sato","year":"2017","journal-title":"Nat Commun"},{"key":"key20230111131732_b35-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"e32542","DOI":"10.1371\/journal.pone.0032542","article-title":"Chemotherapeutics and radiation stimulate MHC class I expression through elevated interferon-beta signaling in breast cancer cells","volume":"7","author":"Wan","year":"2012","journal-title":"PLoS One"},{"key":"key20230111131732_b36-ol-25-01-13628","doi-asserted-by":"publisher","first-page":"e2025840118","DOI":"10.1073\/pnas.2025840118","article-title":"Activation of NF-\u03baB and p300\/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation","volume":"118","author":"Zhou","year":"2021","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T18:57:37Z","timestamp":1701543457000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2022.13628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12,9]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2022.13628","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,9]]},"article-number":"41"}}